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S U M M A R Y
Objectives: Due to the scarce data on the prevalence of sexually transmitted infections (STIs) among
male-to-female trans-sex workers (TSW) and male sex workers (MSW) in Argentina, the present study
aimed to estimate the incidence of human immunodeficiency virus (HIV), and the prevalence of HIV,
hepatitis B virus (HBV), hepatitis C virus (HCV), and Treponema pallidum. Human papillomavirus (HPV)
and Chlamydia trachomatis infections were tested among TSW.
Methods: Two hundred and seventy-three TSW and 114 MSW were recruited by nongovernmental
organizations. HIV incidence was estimated by STARHS (serologic testing algorithm for recent HIV
seroconversion). HPV and C. trachomatis infections were tested in anal cells from TSW.
Results: TSW showed significantly higher prevalences of HIV (34.1 vs. 11.4%), HBV (40.2 vs. 22.0%), and T.
pallidum (50.4 vs. 20.4%) than MSW. TSW tested positive for HPV in 111/114 cases and for C. trachomatis
in 4/80 cases. Investigation of HBV, HCV, HIV, and T. pallidum co-infections showed that 72% of TSW and
39% of MSW had at least one STI. T. pallidum was the most frequent mono-infection. The estimated HIV
incidence was 10.7 per 100 person-years (95% confidence interval (CI) 3.8–17.7) for TSW and 2.3 per 100
person-years (95% CI 0–6.7) for MSW.
Conclusions: The high prevalence of STIs and the high incidence of HIV demonstrate the great
vulnerability of these high-risk populations and indicate the urgent need for preventive strategies on
intervention and facilitation of access to healthcare programs.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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The human immunodeficiency virus (HIV) epidemic in Argentina
is concentrated, since HIV prevalence is consistently over 5.0% in at
least one defined subpopulation.1 Populations with the highest§ Presented in part at the XVII International AIDS Conference, August 3–8, 2008,
Mexico City, Mexico, and AIDS Vaccine 2009, October, 19–22, 2009, Paris, France.
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doi:10.1016/j.ijid.2011.05.007prevalence of infection include injecting drug users (IDUs), non-
injecting cocaine users (NICUs), and men who have sex with men
(MSM).2–4 Following these subpopulations with regard to HIV
prevalence, pregnant women in urban areas exhibit a prevalence of
less than 1.0%, while blood donors exhibit a prevalence of 0.19%.5,6
Data from 1998 to 2008 in our laboratory showed high HIV
prevalence in several high-risk populations: 44.3% in IDUs, 6.3% in
NICUs, 13.8% in MSM (1.6% of whom were engaged in sex work),
17.1% in patients with tuberculosis, 7.2% in patients attending
hospitals in Buenos Aires for consultations on sexually transmitted
infections (STIs), and 3.2% in female sex workers (FSW).2–4,7–9 Noses. Published by Elsevier Ltd. All rights reserved.
M.S. dos Ramos Farı́as et al. / International Journal of Infectious Diseases 15 (2011) e635–e640e636data on seroprevalence are available for male sex workers (MSW),
while only one study so far has assessed HIV and Treponema
pallidum prevalence (27.6% and 42.0%, respectively) among trans-
sex workers (TSW).10 TSW include male-to-female transvestites,
transsexuals, and transgender individuals. This population is
highly vulnerable and marginalized in Argentina, where sex work,
a low level of education, and strong social stigmatization are
conditions associated with a high HIV prevalence.11
Due to the scarce data on HIV and STIs among TSW and MSW in
Argentina, the present study was considered critical to achieve a
better understanding of HIV and STI prevalence in this country.
Therefore, the aim of the present study was to estimate HIV
incidence, and the prevalence of HIV, hepatitis B virus (HBV),
hepatitis C virus (HCV), and T. pallidum infections, as well as the
frequency of co-infections with different pathogens in TSW and
MSW from several cities of Argentina. A group of TSW was also
tested for human papillomavirus (HPV) and Chlamydia trachomatis
infections.
2. Materials and methods
2.1. Recruitment of participants
In the present study, sex workers were defined as adults who
receive money or goods in exchange for sexual services, either
regularly or occasionally, and who identify themselves as sex
workers.12 The study was conducted from October 2006 to
December 2009 in seven cities of Argentina: Buenos Aires, La
Plata, Córdoba, Mendoza, Rosario, Santiago del Estero, and Viedma.
The TSW and MSW included in this study were aged 18 years and
older. Individuals previously diagnosed with the pathogens under
study were also included in the study. Nongovernmental orga-
nizations such as AMMAR (Asociación de Mujeres Meretrices de la
Argentina), ATTTA (Asociación de Travestis, Transexuales y
Transgénero de Argentina), and Nexo AC (which deals mainly
with MSM) were responsible for recruiting the participants.
In each city, sex workers were identified by other peers, invited
to participate in the study, and offered testing and counseling on
STIs. The purpose of the study was explained to all the participants
during the first encounter, and those who chose to participate were
invited to read the informed consent form. After signing the form,
participants were interviewed by a trained peer or social worker
using a standardized questionnaire specific for each group. Results
were linked to the questionnaire by a numeric code that preserved
confidentiality and anonymity.
During the last 18 months of the study, HPV and C. trachomatis
testing and HBV vaccination were offered to TSW attending Nexo
AC. If the participant was found to be HBV-positive, the scheduled
vaccination was reevaluated.
International and national ethics guidelines for biomedical
research involving human subjects were followed (Council for
International Organizations of Medical Sciences, International
Ethical Guidelines for Biomedical Research Involving Human
Subjects; CIOMS 2002, CIOMS 1991). This research was reviewed
by the Nexo AC Institutional Biomedical Review Board (IRB
00005349) and conducted in compliance with all federal regula-
tions governing the protection of human subjects.
2.2. Blood sample collection for diagnosis of HIV, HBV, HCV, and
Treponema pallidum
Samples of anticoagulated and non-anticoagulated blood were
collected in sterile conditions using standard safety precautions
and protocols.
HIV screening was performed by ELISA (Enzygnost Anti-HIV 1/2
Plus ELISA, Dade Behring, Germany) and particle agglutination(Bio-Rad, Fujirebio Diagnostics, Inc., Japan). Reactive samples were
subsequently confirmed by Western blot (New LAV Blot I, Bio-Rad
Laboratories, Inc., WA, USA).
Syphilis infection (past or present) was determined by non-
treponemal and treponemal assays (Venereal Disease Research
Laboratory (VDRL), Wiener Laboratorios, SAIC, Rosario, Argentina;
Treponema pallidum hemagglutination assay (TPHA), Biokit SA,
Barcelona, Spain). An indirect immunofluorescence test (FTA-abs,
Inmunofluor Biocientifica SA, Argentina) was used in the case of
discordant results.
Markers of HBV infection such as surface antigen (HBsAg) and
anti-core antibody (anti-HBc) were determined using ELISA
(HBsAg (V2) Abbott AxSYM System, Core AxSYM System Abbott,
Wiesbaden, Germany). For epidemiological purposes, a sample
was considered HBV-positive if at least one of the markers was
found. In order to determine HCV infection, HCV antibodies were
tested by ELISA (HCV version V3.0, Abbott AxSYM System,
Wiesbaden, Germany).
The participants were scheduled to return in 2 weeks to receive
their HIV, T. pallidum, HBV, and HCV serology results and post-test
counseling. Participants with a positive diagnosis were referred to
clinical centers in order to receive proper evaluation and
treatment. Treatment was offered to those volunteers with current
T. pallidum infection.
2.3. Incidence estimation
The incidence of HIV infection was estimated by STARHS
(serologic testing algorithm for recent HIV seroconversion), as
described elsewhere.13,14 The test consists of a modified enzyme
immunoassay that allows identification of recent infections (time
of infection less than 4–6 months prior to sample collection).
Samples included in this analysis were those obtained up until
October 2009.
2.4. Diagnosis of HPV and Chlamydia trachomatis in samples of anal
mucosa obtained by cytobrush
Due to methodological issues, HPV and C. trachomatis testing
were offered only to TSW participants attending Nexo AC. Those
who accepted were instructed on how to collect the samples (auto-
sampling).
Anal brushing was performed with a cytobrush (Endocervical
brush, Medisul, Argentina); this was stirred in a tube containing
sterile phosphate buffered saline (PBS). The brush was removed and
the tube was centrifuged at 1500 rpm for 10 min. The supernatant
was discarded and the pellet was kept at 20 8C until processing.
Cells were disrupted by proteinase K digestion and tested by
polymerase chain reaction (PCR) for the b-globin gene to confirm the
presence of adequate DNA template.15 HPV DNA detection and
typing was performed as described elsewere.16,17
The ompA gene of C. trachomatis was amplified using a semi-
nested PCR.18 An approximately 1-kb fragment of the ompA gene
was amplified using the primers SERO1A and SERO2A. DNA of C.
trachomatis L2/BU/434 (kindly provided by Sezione di Micro-
biologia DMCSS, Università degli Studi di Bologna, Bologna, Italy)
and mock-infected cells were included as positive and negative
controls, respectively.
One microliter of the first-round PCR product was used for the
semi-nested PCR performed with the same reagents and condi-
tions, except for the primers, which were SERO2A, and one nested
primer: PCTM3. The second-round PCR products were checked on
ethidium bromide-stained 1.5% agarose gels. This semi-nested PCR
was able to detect 1–10 inclusion-forming units.
C. trachomatis genotyping was carried out in all PCR-positive
samples by restriction fragment length polymorphism (RFLP).19
Table 1
Prevalence of sexually transmitted infections among male-to-female trans-sex workers (TSW) and male sex workers (MSW) in Argentina, 2006–2009
TSW MSW p-Value
n/N % (95% CI) n/N % (95% CI)
HIV 93/273 34.1 (28.7–39.9) 13/114 11.4 (6.7–18.7) <0.001
HBV 106/264 40.2 (34.4–46.2) 18/82 22.0 (14.3–32.1) <0.05
HCV 12/264 4.5 (2.5–7.9) 5/82 6.1 (2.3–13.8) NS
Treponema pallidum 130/258 50.4 (44.3–56.4) 23/113 20.4 (13.9–28.8) <0.001
HPV 111/114 97.4 (92.2–99.4) ND ND –
Chlamydia trachomatis 4/80 5.0 (1.6–12.5) ND ND –
Comparisons between proportions were analyzed using the Chi-square test or Fisher’s exact test according to the sample size.
HIV, human immunodeficiency virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HPV, human papillomavirus; ND, not done; NS, not significant.
Figure 1. Frequency of co-infecting agents among 254 male-to-female trans-sex
workers (TSW) with four pathogens tested (HBV, HCV, HIV, and Treponema
pallidum).
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2.5. Statistical analysis
Confidence intervals around proportions were calculated using
the adjusted Wald method. Comparisons between proportions were
analyzed using parametric and non-parametric methods. Univariate
analyses were performed by Chi-square test or Fisher’s exact test
according to the sample size. Statistical analyses were carried out
using SPSS 15.0 (SPSS Inc., Chicago, IL, USA) and Epidat 3.0 ().
3. Results
3.1. Characteristics of the study sample
The study included a population of 273 TSW and 114 MSW (166
TSW and 34 MSW from Buenos Aires City, 22 TSW and 51 MSW
from La Plata, 50 TSW and two MSW from Córdoba, 13 MSW from
Mendoza, five TSW from Rosario, 30 TSW and 13 MSW from
Santiago del Estero, and one MSW from Viedma). Since some cities
had a very small number of participants, results were not stratified
by city. No significant differences were detected between cities
with high numbers of participants (data not shown). Due to
recruitment characteristics, no accurate tracking of individuals
who were invited but did not participate was registered. However,
as estimated by the recruiters, from those invited by AMMAR to
participate in the study, around 90% accepted. In the case of ATTTA,
this value was 50–70%. TSW participants had a median age of 29
years (interquartile range (IQR) 24–35 years), while MSW had a
median age of 27 years (IQR 22–33 years). Most of the participants
were born in Argentina (81.2%). A preliminary analysis of the
epidemiological data from the questionnaire showed that 90% of
TSW preferred male clients and that if they had a steady partner,
95% of them had a male partner. Among MSW, almost 67%
preferred male clients and from those who had a steady partner,
49% had a male partner.
3.2. HIV and other STIs in TSW
In the TSW studied, HIV was detected in 34.1% of the samples,
while the HIV incidence rate was 10.7 per 100 person-years (95%
confidence interval (CI) 3.8–17.7; 85 HIV-positive samples from a
group of 259 TSW). HBV prevalence was 40.2%, and among HBV-
positive participants, only five were HBsAg-positive. HCV was
present in 4.5% and T. pallidum infection in 50.4% (Table 1).
Regarding anal brush sample collection, 119 out of the 140
TSW participants from Buenos Aires attending Nexo AC during
the last 18 months of the study agreed to self-collect the anal
sample. HPV infection was searched for in these 119 samples;
five tested b-globin-negative, leaving 114 samples for assess-
ment. Of these, 97.4% were positive (Table 1). For the samples in
which it was possible to determine the infecting genotype(s)(103/111), high-risk genotypes were detected in 82.5% (85/103),
as shown elsewhere.17,20
The diagnosis of C. trachomatis was performed in 80 TSW. Of
these, 5.0% were positive (Table 1). No venereal lymphogranuloma
genotypes were detected in the samples studied.
Results of co-infections among TSW were analyzed either in the
254 participants who had the four agents tested (HBV, HCV, HIV,
and T. pallidum) or in the 80 volunteers who had the six agents
tested (HBV, HCV, HIV, HPV, T. pallidum, and C. trachomatis) since
the prevalence for each of the four pathogens did not significantly
differ between groups. When results were considered among the
254 TSW, 72% presented at least one infection. The frequencies of
one or two pathogens were each 30%. The most frequent single
infection was T. pallidum (13.8%) and the most frequent co-
infection was HBV–T. pallidum (13.8%), followed by HBV–HIV–T.
pallidum (9.8%) and HIV–T. pallidum (9.4%) (Figure 1). The
prevalence of T. pallidum infection was higher among HBV- and
HIV-positive TSW (p = 0.001 and p = 0.017, respectively).
When considering the 80 participants who had the six agents
tested (Figure 2), the most frequent single infection was HPV
(23.8%) and the most frequent co-infection was HBV–HPV–T.
pallidum (15.0%), followed by HBV–HPV (13.8%).
3.3. HIV and other STIs in MSW
HIV prevalence was 11.4% in MSW, while the incidence rate was
2.3 per 100 person-years (95% CI 0–6.7; 13 HIV-positive samples
Figure 2. Number of sexually transmitted infections (STIs) and frequency of co-infections among male-to-female trans-sex workers (TSW). Results on co-infections were
obtained from 80 participants with six agents tested (HBV, HCV, HIV, HPV, Treponema pallidum, and Chlamydia trachomatis).
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one HBsAg-positive MSW. HCV prevalence was 6.1%. In addition, T.
pallidum infection was detected in 20.4% of MSW (Table 1).
Results on co-infections were obtained for the 82 MSW who had
the four agents tested. Thirty-nine percent of them presented at
least one infection, while the frequency of one pathogen was close
to 20% and that of two agents was around 10%. The most frequent
single infection was that with T. pallidum (11.0%). The most
frequent co-infections were HBV–T. pallidum (6.1%) and HBV–HIV–
T. pallidum (6.1%) (Figure 3). Higher HBV and T. pallidum
prevalences were observed among HIV-positive MSW (p < 0.001
in both cases). HBV-positive MSW showed a higher prevalence of T.
pallidum infection (p = 0.002).
3.4. Comparisons between TSW and MSW groups
HIV, HBV, and T. pallidum prevalence rates were significantly
higher in TSW than in MSW (p < 0.001, p < 0.05, and p < 0.001,
respectively) (Table 1).Figure 3. Frequency of co-infecting agents among 82 male sex workers (MSW) with
four pathogens tested (HBV, HCV, HIV, and Treponema pallidum).When the number of STIs was compared, the frequency of more
than one STI was significantly higher among TSW (42.5% vs. 19.5%,
p < 0.001).
When infecting agents were analyzed (Figures 1 and 3), T.
pallidum was the most frequent single infection, HBV–T. pallidum
was the most frequent double infection, and HBV–HIV–T. pallidum
was the most frequent triple infection in both groups.
4. Discussion
This is the first report that explores HIV and other STI
prevalences among TSW and MSW, since these affected popula-
tions are sparingly accounted for in the dialog concerning the HIV
epidemic in Argentina.
The UNAIDS 2007 Epidemiological Update reported that HIV
transmission in Latin America occurs primarily among MSM and
sex workers. Unprotected sex has become the main route of HIV
transmission in Argentina, with an estimated four out of five new
HIV diagnoses in 2005 attributed to unprotected sex.21 Approxi-
mately 80% of all AIDS cases reported from 2001 to 2007 were
attributed to sexual transmission. Among men, around 30% of the
cases resulted from homosexual intercourse and 40% from
heterosexual intercourse.1
With few studies on the prevalence of HIV among these two
subpopulations, HIV prevalence among TSW in the present study
(34.1%) confirms the high prevalence (27.6%) reported by Toibaro
et al.10 On the other hand, a previous report from the capital city of
Uruguay showed a significantly lower frequency of HIV infection in
this population (21.5%).22 Although the median age was similar in
both samples, the difference may be explained by the years that
have passed between the studies (almost a decade) and the fact
that one study was carried out in only a single city. Meanwhile, the
HIV prevalence among MSW in the present study does not differ
significantly from that previously reported among MSM (13.8%).4
However, a significant difference may be observed if the HIV
prevalence among TSW and MSW is compared to the much lower
one found among FSW (3.2%).9
The finding that HIV prevalence among TSW is higher than
that among MSW in Argentina is consistent with the meta-
analysis reported by Operario et al. Although the differences
were not statistically significant, these authors found an HIV
prevalence of 27.3% among TSW and a prevalence of 15.1%
among MSW.23
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years) was alarmingly high, reinforcing the severity of the
epidemic in this group. This was higher than the incidence
observed among MSW (2.3 per 100 person-years), as well as that
reported among MSM in 2006 (6.7/100 person-years) and that
estimated by Viñoles et al. among TSW in Uruguay (6.03/100
person-years).14,24 In addition to a lower HIV incidence, MSW
declared safer sexual practices than TSW in the present study.
Furthermore, in spite of the existence of a free-of-charge and
easy-to-deliver treatment in Argentina, the prevalence of T.
pallidum was extremely high among TSW, confirming the results
obtained by Toibaro et al. (42.0%).10 Given that MSW and FSW
(45.7%) showed a high prevalence of T. pallidum infection, this
infection is not a public health issue exclusive to TSW.9 These
statistics are evidence of the inadequate or lack of access to
healthcare services that sex workers have.
Given the high HBV prevalence in MSW and TSW, it is
imperative to reach more MSW and TSW in order to provide
them with early vaccination in the context of a well-designed
program. Of note, only 30% of participants who received the first
HBV vaccine dose returned for the second dose. In Argentina, HBV
vaccination has been available since 1982 and has been
recommended for all persons at high-risk of acquiring HBV, such
as MSM, IDUs, heterosexuals with multiple sexual partners or with
some STI, and sex partners of HBV carriers. However, only since
2000 has vaccination for HBV infection became mandatory for
children and preadolescents, but still not for vulnerable popula-
tions.25 A previous study on MSM showed that only 7.0% of a cohort
population had been previously vaccinated against HBV.26 Most
MSM in the study were simply unaware of HBV risks or about the
existence of a vaccine. However, when the vaccine was offered,
nearly 90% of them completed the vaccination schedule.
In contrast to the other pathogens tested, HCV prevalence
among MSW and TSW was relatively low. Russi et al. reported a
similar HCV prevalence among TSW in Uruguay.22 In the present
study, the difference between both populations was not significant
and cannot be related to the use of injecting drugs, given that only
two MSW (both of them HCV-negative) and two TSW (one of them
HCV-positive) reported being IDUs. Given the low chance of HCV
sexual transmission, a higher number of IDUs might have been
involved, although not declared, in this study sample.
This is the first study on HPV prevalence among TSW. In
agreement with the findings of studies among MSM, a high HPV
prevalence was found among TSW.27
The prevalence of C. trachomatis anal infection among TSW in
the present study is higher than that observed (1.85%) in genital
samples from STI symptomatic adult patients of both sexes in
Argentina, but similar to that recently reported in an MSM
population from the USA (6.8%).28,29 A report on TSW from
Indonesia showed that the prevalence of C. trachomatis was 3.8%, a
value very similar to that found in the present study.30 To our
knowledge, this is the first report on C. trachomatis infection in
TSW from Argentina.
T. pallidum was the most frequent single infection. Regarding
the prevalence of co-infections among the four agents tested (HBV,
HCV, HIV, and T. pallidum), detection of STIs among TSW almost
doubled that found among MSW. HIV, HBV, and T. pallidum was a
frequent association in both populations. The interaction between
HIV and other pathogens should be taken into account, since
disease progression may be dramatically altered.
The prevalences of HIV, HBV, HPV, and T. pallidum reported in
the present study are alarmingly high. Regarding vulnerable
populations, MSW and TSW are often excluded from research in
Argentina. The high prevalence of infections observed in the
present study is evidence of both the vulnerability and susceptibly
of these two subpopulations. Particularly alarming are thesignificantly higher rates of infection in TSW. This group has
suffered discrimination and stigmatization for a long time. Sex
work, a job almost mandatory for this group, has led them to a
situation of extreme social marginalization. This social exclusion
and isolation impairs this group’s ability to access public
healthcare services and HIV/AIDS prevention programs, which
should be designed in order to reach them. Given the high
prevalence of STIs observed in this work, it is important to promote
early diagnosis of STIs so that, if necessary, proper treatment can be
initiated and the transmission chain stopped.
Besides, since most TSW clients are men who consider
themselves heterosexuals and have female partners, they may
act as an epidemiological link between TSW and the female
population. Similar considerations should be taken into account as
regards MSW, given that they declared sexual involvement with
both men and women.
The confirmation that HIV and other STIs are concentrated in
specific subpopulations, such as the ones studied in this work, calls
for the urgent provision of preventive interventions and facilita-
tion of access to healthcare programs.
Acknowledgements
This study was supported by the National Research Council
(CONICET) of Argentina (PIP 112-200801-01773) and the Global
Fund (Sub-project N8112). The funding sources had no involve-
ment in the study design, the collection, analysis and interpreta-
tion of data, the writing of the manuscript, or the decision to
submit the manuscript for publication.
The opinions and assertions contained herein are the private
ones of the signing authors. We would like to thank Moira Vignoles,
PhD, for her help with the incidence estimation. Special thanks to
July Romero, Silvana Sosa, Jorgelina Sosa, Miguel Veron and Javier
Aballay for their invaluable secretarial and case management help,
and to Sergio Mazzini and Tim Walsh for the English editing of the
manuscript.
Conflict of interest: None of the authors have any conflict of
interest.
References
1. World Health Organization TB/HIV Working Group of the Global Partnership to
Stop TB and UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance,
2004. Guidelines for HIV Surveillance among Tuberculosis Patients. 2nd ed.
Geneva: WHO; 2004. Available at http://www.paho.org/english/ad/dpc/cd/tb-
hiv-surv-who.htm (accessed 08/02/2010).
2. Weissenbacher M, Rossi D, Radulich G, Sosa-Estani S, Vila M, Vivas E, et al. High
seroprevalence of blood-borne viruses among street-recruited injection drug
users from Buenos Aires, Argentina. Clin Infect Dis 2003;37(Suppl 5):S348–52.
3. Rossi D, Radulich G, Muzzio E, Naveira J, Sosa-Estani S, Rey J, et al. Multiple
infections and associated risk factors among non-injecting cocaine users in
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en América Latina. Lima: Universidad Peruana Cayetano Heredia; 2006, p.
170–1.
12. UNAIDS Technical Update. Sexwork and HIV/AIDS. June 2002. Available at:
http://data.unaids.org/publications/IRC-pub02/jc705-sexwork-tu_en.pdf
(accessed 08/12/2010).
13. Janssen RS, Satten GA, Stramer SL, Rawal BD, O’Brien TR, Weiblen BJ, et al. New
testing strategy to detect early HIV-1 infection for use in incidence estimates
and for clinical and prevention purposes. JAMA 1998;280:42–8.
14. Vignoles M, Avila MM, Osimani ML, Pando MA, Rossi D, Sheppard H, et al. HIV
seroincidence estimates among at-risk populations in Buenos Aires and Mon-
tevideo: use of the serologic testing algorithm for recent HIV seroconversion. J
Acquir Immune Defic Syndr 2006;42:494–500.
15. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-
directed enzymatic amplification of DNA with a thermostable DNA polymerase.
Science 1988;239:487–91.
16. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ.
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-
throughput identification of human papillomavirus genotypes. J Clin Microbiol
2002;40:779–87.
17. dos Ramos Farı́as MS, Picconi MA, Garcia MN, González JV, Basiletti J, Pando MA,
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